JAK inhibitors, or Janus kinase inhibitors, are a class of medication that inhibit the activity of one or more of the Janus kinase family of enzymes. These enzymes play a crucial role in the signaling pathways that control the growth and survival of cells, including cancerous cells. JAK inhibitors have emerged as a promising treatment option for various types of cancer due to their ability to interfere with these pathways.
